WAKAYAMA MEDICAL UNIVERSITY

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: Private

Established: 1945-01-01

Employees: -

Market Cap: -

Website: http://www.wakayama-med.ac.jp/intro/index.html

Clinical Trials

Change in Plaque Characteristics With Atorvastatin

Phase 4

Completed

Conditions: Atherosclerosis
Acute Coronary Syndrome
Dyslipidemia

Interventions: Drug: high-dose atorvastatin
Drug: low-dose atorvastatin

First Posted Date: 2008-06-18

Last Posted Date: 2014-10-29

Lead Sponsor: Wakayama Medical University

Target Recruit Count: 70

Registration Number: NCT00700037

Locations: 🇯🇵
Wakayama Medical University, Wakayama, Japan

PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer

Phase 1

Conditions: Esophageal Cancer

First Posted Date: 2008-04-30

Last Posted Date: 2010-09-09

Lead Sponsor: Wakayama Medical University

Target Recruit Count: 29

Registration Number: NCT00669292

Locations: 🇯🇵
Wakayama Medical University Hospital, 811-1 Kimiidera, Wakayama, Wakayama, Japan

Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy

Not Applicable

Completed

Conditions: Pancreatic Cancer
Bile Duct Cancer
Ampullary Cancer
Duodenal Cancer
Pancreatitis

Interventions: Procedure: pylorus-resecting pancreaticoduodenectomy
Procedure: pylorus-preserving pancreaticoduodenectomy

First Posted Date: 2008-03-20

Last Posted Date: 2011-06-27

Lead Sponsor: Wakayama Medical University

Target Recruit Count: 130

Registration Number: NCT00639314

Locations: 🇯🇵
Second Department of Surgery, Wakayama Medical University, School of Medicine, 811-1 Kimiidera, Wakayama, Japan

Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy

Not Applicable

Completed

Conditions: Bile Duct Cancer
Pancreatitis
Duodenal Cancer
Pancreatic Cancer
Ampullary Cancer

Interventions: Device: external drainage tube [polyethylene pancreatic drainage tube]
Device: internal drainage tube [polyethylene pancreatic drainage tube]

First Posted Date: 2008-03-04

Last Posted Date: 2010-01-18

Lead Sponsor: Wakayama Medical University

Target Recruit Count: 100

Registration Number: NCT00628186

Locations: 🇯🇵
Wakayama Medical University , Second Department of Surgery, 811-1 Kimiidera, Wakayama, Wakayama, Japan

Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer

Phase 1

Completed

Conditions: Pancreatic Cancer

Interventions: Biological: VEGFR2-169 and gemcitabine

First Posted Date: 2008-02-25

Last Posted Date: 2009-02-18

Lead Sponsor: Wakayama Medical University

Target Recruit Count: 21

Registration Number: NCT00622622

Locations: 🇯🇵
Wakayama Medical University Hospital, 811-1 Kimiidera, Wakayama, Wakayama, Japan

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy